D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 73 Citations 19,145 732 World Ranking 15750 National Ranking 810

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Visual acuity

His primary scientific interests are in Cornea, Lymphangiogenesis, Ophthalmology, Pathology and Surgery. His Cornea research includes elements of Angiogenesis, Corneal neovascularization and Neovascularization. His work deals with themes such as Inflammation, Lymphatic system, Immunology, Vascular endothelial growth factor A and Cell biology, which intersect with Lymphangiogenesis.

Claus Cursiefen interconnects Receptor, CD31, Endothelium and Lymph in the investigation of issues within Lymphatic system. His Biopsy study in the realm of Pathology interacts with subjects such as Basal cell carcinoma. In his research, Corneal allograft rejection, Allograft rejection, Atopic dermatitis, Endothelial corneal allograft rejection and Immune reaction is intimately related to Incidence, which falls under the overarching field of Surgery.

His most cited work include:

  • VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment (827 citations)
  • Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages (576 citations)
  • Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages (576 citations)

What are the main themes of his work throughout his whole career to date?

Claus Cursiefen mainly focuses on Ophthalmology, Cornea, Pathology, Lymphangiogenesis and Surgery. In his work, Bevacizumab is strongly intertwined with Corneal neovascularization, which is a subfield of Ophthalmology. His work carried out in the field of Cornea brings together such families of science as Neovascularization and Transplantation.

His Pathology study frequently draws connections to other fields, such as Melanoma. His Lymphangiogenesis research is multidisciplinary, incorporating perspectives in Inflammation, Immunology and Cancer research, Angiogenesis. His Lymphatic system research is multidisciplinary, incorporating elements of CD31 and Lymphatic vessel.

He most often published in these fields:

  • Ophthalmology (35.94%)
  • Cornea (22.09%)
  • Pathology (19.44%)

What were the highlights of his more recent work (between 2017-2021)?

  • Ophthalmology (35.94%)
  • Descemet membrane (11.19%)
  • Cornea (22.09%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Ophthalmology, Descemet membrane, Cornea, Gynecology and Visual acuity. While the research belongs to areas of Ophthalmology, Claus Cursiefen spends his time largely on the problem of Corneal neovascularization, intersecting his research to questions surrounding Clinical trial. His work on Fuchs Endothelial Dystrophy as part of general Descemet membrane study is frequently connected to Outcome measures, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.

His Cornea research includes themes of Lymphatic system, Transplantation and Lymphangiogenesis. His research in Lymphangiogenesis focuses on subjects like Angiogenesis, which are connected to Pathology. His studies deal with areas such as Significant difference, Retrospective cohort study and Cataract surgery as well as Visual acuity.

Between 2017 and 2021, his most popular works were:

  • Trends in Corneal Transplantation from 2001 to 2016 in Germany: A Report of the DOG–Section Cornea and its Keratoplasty Registry (78 citations)
  • Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis. (71 citations)
  • Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation. (34 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Ophthalmology

Claus Cursiefen spends much of his time researching Ophthalmology, Cornea, Descemet membrane, Lymphatic system and Lymphangiogenesis. Claus Cursiefen has researched Cornea in several fields, including Immune privilege and Surgery, Transplantation. His Descemet membrane research focuses on subjects like Lamellar keratoplasty, which are linked to Significant difference, Endothelial cell count, Donor tissue, Retrospective review and Endothelial cell density.

His Lymphatic system study introduces a deeper knowledge of Pathology. His Pathology research incorporates elements of Corneal Injury and Corneal wound. His Lymphangiogenesis study combines topics from a wide range of disciplines, such as Angiogenesis and Lymphatic vessel.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment

Claus Cursiefen;Lu Chen;Leonardo P. Borges;David Jackson.
Journal of Clinical Investigation (2004)

1161 Citations

Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages

Kazuichi Maruyama;Masaaki Ii;Claus Cursiefen;Claus Cursiefen;David G. Jackson.
Journal of Clinical Investigation (2005)

774 Citations

Descemet Membrane Endothelial Keratoplasty Versus Descemet Stripping Automated Endothelial Keratoplasty

Theofilos Tourtas;Kathrin Laaser;Bjoern O. Bachmann;Claus Cursiefen.
American Journal of Ophthalmology (2012)

413 Citations

Influence of Photodynamic Therapy on Expression of Vascular Endothelial Growth Factor (VEGF), VEGF Receptor 3, and Pigment Epithelium–Derived Factor

Ursula Schmidt-Erfurth;Ursula Schlötzer-Schrehard;Claus Cursiefen;Stephan Michels.
Investigative Ophthalmology & Visual Science (2003)

408 Citations

Inhibition of Hemangiogenesis and Lymphangiogenesis after Normal–Risk Corneal Transplantation by Neutralizing VEGF Promotes Graft Survival

Claus Cursiefen;Jingtai Cao;Lu Chen;Ying Liu.
Investigative Ophthalmology & Visual Science (2004)

363 Citations

Bevacizumab as a Potent Inhibitor of Inflammatory Corneal Angiogenesis and Lymphangiogenesis

Felix Bock;Jasmine Onderka;Tina Dietrich;Bjo¨rn Bachmann.
Investigative Ophthalmology & Visual Science (2007)

356 Citations

Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.

Claus Cursiefen;Ursula Schlötzer-Schrehardt;Michael Küchle;Lydia Sorokin.
Investigative Ophthalmology & Visual Science (2002)

310 Citations

Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation

Tina Dietrich;Felix Bock;Felix Bock;Don Yuen;Deniz Hos.
Journal of Immunology (2010)

279 Citations

A stepwise approach to donor preparation and insertion increases safety and outcome of Descemet membrane endothelial keratoplasty.

Friedrich E Kruse;Kathrin Laaser;Claus Cursiefen;Ludwig M Heindl.
Cornea (2011)

278 Citations

Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.

Claus Cursiefen;Lu Chen;Magali Saint-Geniez;Pedram Hamrah.
Proceedings of the National Academy of Sciences of the United States of America (2006)

271 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Claus Cursiefen

Reza Dana

Reza Dana

Massachusetts Eye and Ear Infirmary

Publications: 96

Kari Alitalo

Kari Alitalo

University of Helsinki

Publications: 38

Michael Detmar

Michael Detmar

ETH Zurich

Publications: 30

Ursula Schlötzer-Schrehardt

Ursula Schlötzer-Schrehardt

University of Erlangen-Nuremberg

Publications: 29

Shigeru Kinoshita

Shigeru Kinoshita

Kyoto Prefectural University of Medicine

Publications: 25

Ursula Schmidt-Erfurth

Ursula Schmidt-Erfurth

Medical University of Vienna

Publications: 25

Robert Ritch

Robert Ritch

New York Eye and Ear Infirmary

Publications: 25

Kazuo Tsubota

Kazuo Tsubota

Keio University

Publications: 25

Dimitri T. Azar

Dimitri T. Azar

Twenty/Twenty Therapeutics

Publications: 21

Harminder S Dua

Harminder S Dua

University of Nottingham

Publications: 18

Jerry Y. Niederkorn

Jerry Y. Niederkorn

The University of Texas Southwestern Medical Center

Publications: 18

Shiro Amano

Shiro Amano

University of Tokyo

Publications: 17

Gottfried O. H. Naumann

Gottfried O. H. Naumann

University of Erlangen-Nuremberg

Publications: 15

Rayaz A. Malik

Rayaz A. Malik

Weill Cornell Medical College in Qatar

Publications: 14

Stefano Ferrari

Stefano Ferrari

Veneto Eye Bank Foundation

Publications: 14

Alexander Steinkasserer

Alexander Steinkasserer

University of Erlangen-Nuremberg

Publications: 14

Trending Scientists

Michael Peter Kennedy

Michael Peter Kennedy

University College Dublin

Mita Nasipuri

Mita Nasipuri

Jadavpur University

Cameron Hepburn

Cameron Hepburn

University of Oxford

Edward E. Leamer

Edward E. Leamer

University of California, Los Angeles

Ling Wang

Ling Wang

Tsinghua University

Ian G. Macara

Ian G. Macara

Vanderbilt University

Ravi Iyengar

Ravi Iyengar

Icahn School of Medicine at Mount Sinai

Sandra Gessani

Sandra Gessani

Istituto Superiore di Sanità

Gilles A. Lajoie

Gilles A. Lajoie

University of Western Ontario

Thomas Stamminger

Thomas Stamminger

University of Erlangen-Nuremberg

Lamberto Maffei

Lamberto Maffei

Accademia Nazionale dei Lincei

Simon P. Kelly

Simon P. Kelly

University College Dublin

Marvin Zuckerman

Marvin Zuckerman

University of Delaware

Roland Bammer

Roland Bammer

Monash University

Assen Jablensky

Assen Jablensky

University of Western Australia

Marshall Burke

Marshall Burke

Stanford University

Something went wrong. Please try again later.